NADAC acquisition cost data for DIGOX 125 MCG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00527132401 | $0.1847 | 2022-12-21 | Rx |
| 00527132410 | $0.1847 | 2022-12-21 | Rx |
| 00527132401 | $0.1847 | 2022-12-21 | Rx |
| 00527132410 | $0.1847 | 2022-12-21 | Rx |
Generic: Digoxin | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $68.2M | 1,928,245 | 479,207 | $0.6757 |
| 2020 | $75.9M | 2,135,517 | 478,178 | $0.6515 |
| 2021 | $66.5M | 1,962,226 | 454,232 | $0.6100 |
| 2022 | $57.6M | 1,814,500 | 424,245 | $0.5739 |
| 2023 | $49.7M | 1,675,559 | 392,747 | $0.5408 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.